Advertisement

Advertisement

HK:2289 Stock Latest News

Charmacy Pharmaceutical Sets Board Meeting to Review 2026 Interim Results and Dividend

Company AnnouncementsCharmacy Pharmaceutical Sets Board Meeting to Review 2026 Interim Results and Dividend

Charmacy Pharmaceutical Wins Shareholder Backing for Dividend, Credit Line and Share Mandate

PremiumCompany Announcements

Charmacy Pharmaceutical Wins Shareholder Backing for Dividend, Credit Line and Share Mandate

3M ago

Charmacy Pharmaceutical Sets Final 2025 Dividend and Clarifies Tax Treatment

PremiumCompany Announcements

Charmacy Pharmaceutical Sets Final 2025 Dividend and Clarifies Tax Treatment

3M ago

Charmacy Pharmaceutical Sets 2026 AGM to Approve Dividend, Credit Line and Share Issue Mandate

PremiumCompany Announcements

Charmacy Pharmaceutical Sets 2026 AGM to Approve Dividend, Credit Line and Share Issue Mandate

4M ago

Charmacy Pharmaceutical Sets Updated Final Dividend and Outlines Tax Treatment

PremiumCompany Announcements

Charmacy Pharmaceutical Sets Updated Final Dividend and Outlines Tax Treatment

4M ago

Charmacy Pharmaceutical Corrects EPS and ROE Note in 2025 Results

PremiumCompany AnnouncementsCharmacy Pharmaceutical Corrects EPS and ROE Note in 2025 Results

5M ago

Charmacy Pharmaceutical Sets Final 2025 Dividend at RMB 0.3 per Share

Company Announcements

Charmacy Pharmaceutical Sets Final 2025 Dividend at RMB 0.3 per Share

5M ago

Charmacy Pharmaceutical Reshapes Company Secretarial and Governance Roles

Company Announcements

Charmacy Pharmaceutical Reshapes Company Secretarial and Governance Roles

5M ago

Charmacy Pharmaceutical Profit Slips in 2025 but Dividend Held

PremiumCompany Announcements

Charmacy Pharmaceutical Profit Slips in 2025 but Dividend Held

5M ago

Charmacy Pharmaceutical Declares Final 2025 Dividend of RMB 0.3 per Share

PremiumCompany Announcements

Charmacy Pharmaceutical Declares Final 2025 Dividend of RMB 0.3 per Share

5M ago

Charmacy Pharmaceutical Sets Board Meeting to Approve 2025 Results and Consider Final Dividend

PremiumCompany Announcements

Charmacy Pharmaceutical Sets Board Meeting to Approve 2025 Results and Consider Final Dividend

5M ago

Charmacy Pharmaceutical Approves Key Resolutions at EGM

PremiumCompany Announcements

Charmacy Pharmaceutical Approves Key Resolutions at EGM

9M ago

Charmacy Pharmaceutical Announces EGM to Discuss Key Resolutions

PremiumCompany AnnouncementsCharmacy Pharmaceutical Announces EGM to Discuss Key Resolutions

9M ago

Charmacy Pharmaceutical Proposes Auditor Change to Pan-China

Company Announcements

Charmacy Pharmaceutical Proposes Auditor Change to Pan-China

10M ago

Charmacy Pharmaceutical Renews Framework Loan Agreement with Jiangyao

Company Announcements

Charmacy Pharmaceutical Renews Framework Loan Agreement with Jiangyao

10M ago

Charmacy Pharmaceutical Proposes Governance Restructuring

PremiumCompany Announcements

Charmacy Pharmaceutical Proposes Governance Restructuring

10M ago

Charmacy Pharmaceutical Reports Decline in Interim Revenue and Profit

PremiumCompany Announcements

Charmacy Pharmaceutical Reports Decline in Interim Revenue and Profit

12M ago

Charmacy Pharmaceutical Schedules Board Meeting to Review Interim Results

PremiumCompany Announcements

Charmacy Pharmaceutical Schedules Board Meeting to Review Interim Results

1y ago

Charmacy Pharmaceutical Co., Ltd. Enhances Governance with New Nomination Committee

PremiumCompany Announcements

Charmacy Pharmaceutical Co., Ltd. Enhances Governance with New Nomination Committee

1y ago

Charmacy Pharmaceutical Updates Nomination Committee Composition

PremiumCompany AnnouncementsCharmacy Pharmaceutical Updates Nomination Committee Composition

1y ago

Charmacy Pharmaceutical Announces Board and Committee Structures

Company Announcements

Charmacy Pharmaceutical Announces Board and Committee Structures

1y ago

Charmacy Pharmaceutical Announces Final Dividend for 2024

Company Announcements

Charmacy Pharmaceutical Announces Final Dividend for 2024

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >